Join the DDA or

Emerade AAI shortage alert

CAS published to cover short-term disruption

August 5th 2019

Tagged: supply shortages

By Ailsa Colquhoun

Bausch & Lomb have advised of a supply issue with Emerade 300mcg and 500 mcg adrenaline auto-injector (AAI) devices.

Due to short term disruption, the company expects to be out of stock of the 500mcg strength until Wednesday 28 August, and for 300mcg strength between early-mid August until end of September.

A Central Alerting System (CAS) update has been published offering guidance on the supply issue and on switching patients to alternative adrenaline auto-injector pens.

DHSC has confirmed that there should be sufficient quantities of  stock from alternate AAI suppliers to support the whole UK market during this period.

For all the latest news of the 2019 DDA annual conference...

Learn more